Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
Stephanie A. Schultz,Jeremy F. Strain,Adedamola Adedokun,Qing Wang,Oliver Preische,Jens Kuhle,Shaney Flores,Sarah Keefe,Aylin Dincer,Beau M. Ances,Sarah B. Berman,Adam M. Brickman,David M. Cash,Jasmeer Chhatwal,Carlos Cruchaga,Michael Ewers,Nick N. Fox,Bernardino Ghetti,Alison Goate,Neill R. Graff-Radford,Jason J. Hassenstab,Russ Hornbeck,Clifford Jack,Keith Johnson,Nelly Joseph-Mathurin,Celeste M. Karch,Robert A. Koeppe,Athene K.W. Lee,Johannes Levin,Colin Masters,Eric McDade,Richard J. Perrin,Christopher C. Rowe,Stephen Salloway,Andrew J. Saykin,Reisa Sperling,Yi Su,Victor L. Villemagne,Jonathan Vöglein,Michael Weiner,Chengjie Xiong,Anne M. Fagan,John C. Morris,Randall J. Bateman,Tammie L.S. Benzinger,Mathias Jucker,Brian A. Gordon,for the Dominantly Inherited Alzheimer Network
DOI: https://doi.org/10.1016/j.nbd.2020.104960
IF: 7.046
2020-08-01
Neurobiology of Disease
Abstract:Neurofilament light chain (NfL) is a protein that is selectively expressed in neurons. Increased levels of NfL measured in either cerebrospinal fluid or blood is thought to be a biomarker of neuronal damage in neurodegenerative diseases. However, there have been limited investigations relating NfL to the concurrent measures of white matter (WM) decline that it should reflect. White matter damage is a common feature of Alzheimer's disease. We hypothesized that serum levels of NfL would associate with WM lesion volume and diffusion tensor imaging (DTI) metrics cross-sectionally in 117 autosomal dominant mutation carriers (MC) compared to 84 non-carrier (NC) familial controls as well as in a subset (N = 41) of MC with longitudinal NfL and MRI data. In MC, elevated cross-sectional NfL was positively associated with WM hyperintensity lesion volume, mean diffusivity, radial diffusivity, and axial diffusivity and negatively with fractional anisotropy. Greater change in NfL levels in MC was associated with larger changes in fractional anisotropy, mean diffusivity, and radial diffusivity, all indicative of reduced WM integrity. There were no relationships with NfL in NC. Our results demonstrate that blood-based NfL levels reflect WM integrity and supports the view that blood levels of NfL are predictive of WM damage in the brain. This is a critical result in improving the interpretability of NfL as a marker of brain integrity, and for validating this emerging biomarker for future use in clinical and research settings across multiple neurodegenerative diseases.
neurosciences